Stephen Aselage
Director/Board Member at BIOCRYST PHARMACEUTICALS, INC.
Net worth: 321 762 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeff Ajer | M | 61 |
SangStat Medical Corp.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 21 years |
Gary Lyons | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 21 years |
R. Clifton | M | 51 | 1 years | |
Helen Thackray | M | 55 | 5 years | |
Chris Cline | M | 40 | 10 years | |
George Abercrombie | M | 69 | 13 years | |
Eric Dube | M | 51 | 5 years | |
Anthony Doyle | M | 44 | 4 years | |
Nancy Hutson | M | 74 | 12 years | |
John Orwin | M | 59 |
SangStat Medical Corp.
| 10 years |
Randy Meier | M | 65 | 18 years | |
Jeffrey Meckler | M | 57 | 10 years | |
Jon Stonehouse | M | 63 | 17 years | |
Elizabeth Reed | F | 53 | 7 years | |
A. Sanders | F | 60 | 2 years | |
Alane Barnes | F | 58 | 18 years | |
Theresa Heggie | F | 63 | 6 years | |
Philip Lo Scalzo | M | - | 17 years | |
Alan Levin | M | 62 | 4 years | |
Sandra E. Poole | F | 60 | 5 years | |
Ryan Arnold | M | - | 2 years | |
Sandra Calvin | F | 59 | 10 years | |
Amy McKee | M | 52 | 3 years | |
Tanya Hayden | F | 44 | 3 years | |
Thomas Madden | M | - |
Acuitas Therapeutics, Inc.
Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden. | - |
Jason Kneeland | M | - | 7 years | |
Steven Galson | M | 67 | 3 years | |
William P. Sheridan | M | 69 | 16 years | |
Ron Squarer | M | 57 | 7 years | |
V. Lawlis | M | 72 | 17 years | |
Ruth Williams-Brinkley | F | 72 | 3 years | |
Roy Baynes | M | 69 | 8 years | |
Henry Fuchs | M | 66 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 25 years |
Pravin Soni | M | - |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | 11 years |
Jefferson E. Davis | M | 57 | 9 years | |
Vin Milano Milano | M | 60 | 3 years | |
Suzanne Bruhn | M | 60 | 4 years | |
Stuart Bunting | M | - | 16 years | |
Tim Coughlin | M | 57 | 9 years | |
Donald Joseph | M | 70 | 6 years | |
Charles Gayer | M | 53 | 9 years | |
Catherine Collier Kyroulis | F | - | - | |
Jinky Ang Rosselli | F | - | 9 years | |
Joshua Schafer | M | 53 | 1 years | |
Jula Inrig | M | 49 | 2 years | |
Bernie Paul | M | 65 | 5 years | |
Renee Carroll | F | - | 4 years | |
Brad Glasscock | M | - | 12 years | |
Peter Heerma | M | 53 | 5 years | |
Stephanie Angelini | F | - | 6 years | |
Bill Rote | M | 61 | 7 years | |
Robert Armstrong | M | - |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | - |
Salisa Hauptmann | F | - | 3 years | |
Esther van den Boom | F | 45 |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | - |
Casey H. Logan | M | 52 | 6 years | |
Kim Tharaldsen | F | - | 6 years | |
John D. Bluth | M | - | 5 years | |
Eduardo Von Pervieux | M | - | 16 years | |
Yarlagadda S. Babu | M | 71 | 36 years | |
Rod M. Saponjic | M | - |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | - |
Philip George | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Martin Shkreli | M | 41 |
Desert Gateway, Inc.
Desert Gateway, Inc. Financial ConglomeratesFinance Desert Gateway, Inc. operates as a capital pool company. It is presently a development stage company seeking a potential acquisition of or merger with a yet to be identified business opportunity. The company was founded on February 8, 2008 and is headquartered in Bartlesville, OK.
Retrophin LLC
Retrophin LLC BiotechnologyHealth Technology Retrophin, Inc. provides biotechnology services. It is a biotechnology company dedicated to developing drugs for rare and life-threatening diseases. The company was founded in 2011 and is headquartered in New York, NY. | 6 years |
Robert Wilson | M | 54 |
Desert Gateway, Inc.
Desert Gateway, Inc. Financial ConglomeratesFinance Desert Gateway, Inc. operates as a capital pool company. It is presently a development stage company seeking a potential acquisition of or merger with a yet to be identified business opportunity. The company was founded on February 8, 2008 and is headquartered in Bartlesville, OK. | 5 years |
Christopher Schelling | M | 48 | 13 years | |
Steven Gary Richardson | M | 70 |
Desert Gateway, Inc.
Desert Gateway, Inc. Financial ConglomeratesFinance Desert Gateway, Inc. operates as a capital pool company. It is presently a development stage company seeking a potential acquisition of or merger with a yet to be identified business opportunity. The company was founded on February 8, 2008 and is headquartered in Bartlesville, OK. | 3 years |
Thomas Staab | M | 56 | 9 years | |
Dan Spiegelman | M | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 16 years |
Jean-Jacques Bienaimé | M | 70 |
SangStat Medical Corp.
| 4 years |
Harry Palmin | M | 54 | 6 years | |
David Kreuter | M | - |
University of Notre Dame
| 7 years |
Jason Amello | M | 55 | 6 years | |
Kevin M. Butler | M | 68 |
University of Notre Dame
| 6 years |
Gerald Eugene O'Shaughnessy | M | 75 |
University of Notre Dame
| 7 years |
Tom C. Gores | M | - |
University of Notre Dame
| 7 years |
Jerry Cacia | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 years |
Michelle Griffin | F | 58 | 6 years | |
Laura Clague | F | 64 | 8 years | |
Charles J. Dougherty | M | 75 |
University of Notre Dame
| 2 years |
Clint D. Gibler | M | 71 |
University of Notre Dame
| 6 years |
Hubert Birner | M | 57 | 2 years | |
Bill Donovan | M | 71 |
University of Notre Dame
| 6 years |
Luc Marengère | M | 59 | 2 years | |
Fred Cohen | M | 67 | 6 years | |
Marc L. Panoff | M | 53 | 1 years | |
John Kozarich | M | 74 | 5 years | |
Margaret E. Valeur-Jensen | M | 67 | - | |
John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 years |
Louis C. Drapeau | M | 79 | 3 years | |
John F. Gaither | M | 74 |
University of Notre Dame
| 7 years |
Richard E. Leigh | M | 64 | 1 years | |
Brian Lundstrom | M | 61 |
SangStat Medical Corp.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
Cornelius E. Golding | M | 76 | - | |
William Young | M | 79 | 5 years | |
Christopher Starr | M | 71 | 9 years | |
John Dunn | M | 72 | 6 years | |
Tom McIntyre | M | - |
University of Notre Dame
| 6 years |
Kenneth Lee | M | 76 | 12 years | |
Michael Grey | M | 71 | 16 years | |
Ken Bate | M | 73 | 7 years | |
Michael Jones | M | 54 | 13 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 99.00% |
Canada | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen Aselage
- Personal Network